Performance of global assessments of hip, knee, and back symptom change
- PMID: 20683742
- PMCID: PMC3731381
- DOI: 10.1007/s10067-010-1536-x
Performance of global assessments of hip, knee, and back symptom change
Abstract
The objective of this study is to compare patients' global assessments of change in knee, hip, and back symptoms with actual changes over time in pain, function, and radiographic severity. The participants (n = 894, 80% female, mean age = 66 years) completed two assessments (mean of 4 years apart) as part of a study on the genetics of generalized osteoarthritis. At both assessments, participants completed the Western Ontario and McMaster Universities OA Index (WOMAC), and radiographic severity was assessed for knees, hips, and low back. At the second assessment, participants described changes in knee, hip, and low back symptoms as worse, better, same, or never had symptoms. Analysis of covariance models examined mean changes in WOMAC scores and radiographic severity according to categories of the global assessment measures. Statistical significance was examined for linear trend. Mean WOMAC total, pain, and function scores decreased (indicating improvement) among participants who indicated joint symptoms were better, showed little change among those who reported symptoms were the same/never had symptoms, and increased among those who reported symptoms were worse. For all analyses except the comparison of WOMAC pain change according to global assessment of low back symptom change, there was a statistically significant linear trend (p < 0.05). Patterns were similar for changes in radiographic severity, but the tests of linear trend were not statistically significant. Results support the concordance of these global assessments of joint symptom change with actual changes in self-reported symptoms. These global assessments may be useful for assessing change over time when baseline data are unavailable.
Figures
Similar articles
-
Racial differences in self-reported pain and function among individuals with radiographic hip and knee osteoarthritis: the Johnston County Osteoarthritis Project.Osteoarthritis Cartilage. 2009 Sep;17(9):1132-6. doi: 10.1016/j.joca.2009.03.003. Epub 2009 Mar 18. Osteoarthritis Cartilage. 2009. PMID: 19327733 Free PMC article.
-
Minimal clinically important decline in physical function over one year: EPOSA study.BMC Musculoskelet Disord. 2019 May 17;20(1):227. doi: 10.1186/s12891-019-2593-1. BMC Musculoskelet Disord. 2019. PMID: 31101033 Free PMC article.
-
Symptom assessment in knee osteoarthritis needs to account for physical activity level.Arthritis Rheumatol. 2015 Nov;67(11):2897-904. doi: 10.1002/art.39271. Arthritis Rheumatol. 2015. PMID: 26407008 Free PMC article.
-
Disease-specific pain and function predict future pain impact in hip and knee osteoarthritis.Clin Rheumatol. 2016 Dec;35(12):2999-3005. doi: 10.1007/s10067-016-3401-z. Epub 2016 Sep 6. Clin Rheumatol. 2016. PMID: 27601231
-
Is adiposity associated with back and lower limb pain? A systematic review.PLoS One. 2021 Sep 14;16(9):e0256720. doi: 10.1371/journal.pone.0256720. eCollection 2021. PLoS One. 2021. PMID: 34520462 Free PMC article.
Cited by
-
Use of patient-reported global assessment measures in clinical trials of chronic pain treatments: ACTTION systematic review and considerations.Pain. 2024 Nov 1;165(11):2445-2454. doi: 10.1097/j.pain.0000000000003270. Epub 2024 May 14. Pain. 2024. PMID: 38743561
-
Patient and provider interventions for managing osteoarthritis in primary care: protocols for two randomized controlled trials.BMC Musculoskelet Disord. 2012 Apr 24;13:60. doi: 10.1186/1471-2474-13-60. BMC Musculoskelet Disord. 2012. PMID: 22530979 Free PMC article. Clinical Trial.
References
-
- Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. The Journal of Rheumatology. 1988;15:1833–1840. - PubMed
-
- Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. The Journal of Rheumatology. 1997;24:799–802. - PubMed
-
- Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, Simon L, Strand V, Woodworth T, Dougados M. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials. Osteoarthritis & Cartilage. 2004;12:389–399. - PubMed
-
- Chevalier X, Mejjad O, Babini S. Methodology for the assessment of treatments in hand osteoarthritis. Osteoarthritis & Cartilage. 2000;8 (Supplement A):S70–S72. - PubMed
-
- Lequesne MG, Maheu E. Methodology of clinical trials in hand osteoarthritis: conventional and proposed tools. Osteoarthritis & Cartilage. 2000;8 (Suppl A):S64–S69. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical